Insider trade

Precision Biosciences (DTIL)CEO sold ~$25K

Michael Amoroso, CEO at Precision Biosciences, sold ~$25K of Precision Biosciences shares.

~$25K
Approx. value · 3,012 sh @ $8.19: 29K
Holds after · shares reported

Traded: Nov 4, 2024
Filed: Nov 6, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Nov 4, 2024 · this disclosureInsiderCEO sold ~$25K of DTIL shares in the open market

What came next

Nov 4, 2024InsiderOfficer sold ~$4.8K of DTIL shares in the open market
Nov 21, 2024InsiderCFO purchased ~$20K of DTIL shares in the open market
Dec 26, 2024InsiderDirector purchased ~$14K of DTIL shares in the open market
Dec 27, 2024Insider · 2 peopleInsiders: 2 purchases (~$31K)
Dec 30, 2024InsiderDirector purchased ~$16K of DTIL shares in the open market
Jan 21, 2025InsiderCEO sold ~$172K of DTIL shares in the open market
Jan 22, 2025Insider · 2 peopleInsiders: 2 sales (~$92K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Precision Biosciences

For Precision Biosciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DTIL page.

Other recent filings by Michael Amoroso, President and CEO

The full history of Michael Amoroso, President and CEO is on the profile page.

How this filing works

Other disclosures at Precision Biosciences

Everything OQRO holds on this company is on its DTIL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data